Nu Skin Enterprises (NYSE:NUS) Price Target Cut to $6.75

Nu Skin Enterprises (NYSE:NUS) had its target price reduced by research analysts at Citigroup from $11.50 to $6.75 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the stock. Citigroup’s price target indicates a potential upside of 10.47% from the stock’s previous close.

Several other brokerages have also recently issued reports on NUS. StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Friday, September 6th. DA Davidson dropped their price target on shares of Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating on the stock in a research note on Monday, August 12th.

Nu Skin Enterprises Trading Down 0.8 %

NYSE NUS traded down $0.05 during trading on Tuesday, hitting $6.11. 403,752 shares of the company’s stock traded hands, compared to its average volume of 849,153. The stock has a fifty day moving average of $7.76 and a two-hundred day moving average of $10.46. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 1.33. Nu Skin Enterprises has a 12-month low of $5.99 and a 12-month high of $20.75. The firm has a market cap of $303.47 million, a P/E ratio of -101.17 and a beta of 1.12.

Nu Skin Enterprises (NYSE:NUS) last announced its earnings results on Thursday, August 8th. The company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.04. Nu Skin Enterprises had a negative net margin of 8.05% and a positive return on equity of 7.80%. The business had revenue of $439.10 million during the quarter, compared to the consensus estimate of $431.87 million. During the same quarter last year, the firm earned $0.54 earnings per share. The business’s revenue for the quarter was down 12.2% on a year-over-year basis. As a group, sell-side analysts expect that Nu Skin Enterprises will post 0.78 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the stock. CWM LLC grew its stake in Nu Skin Enterprises by 38.4% during the 1st quarter. CWM LLC now owns 3,286 shares of the company’s stock valued at $45,000 after purchasing an additional 911 shares during the last quarter. Public Employees Retirement System of Ohio grew its position in shares of Nu Skin Enterprises by 30.5% in the first quarter. Public Employees Retirement System of Ohio now owns 3,926 shares of the company’s stock valued at $54,000 after purchasing an additional 918 shares in the last quarter. The Manufacturers Life Insurance Company grew its position in shares of Nu Skin Enterprises by 6.0% in the second quarter. The Manufacturers Life Insurance Company now owns 19,262 shares of the company’s stock valued at $203,000 after purchasing an additional 1,096 shares in the last quarter. SummerHaven Investment Management LLC grew its position in Nu Skin Enterprises by 4.7% in the second quarter. SummerHaven Investment Management LLC now owns 25,778 shares of the company’s stock worth $272,000 after acquiring an additional 1,152 shares during the period. Finally, Signaturefd LLC grew its position in Nu Skin Enterprises by 72.6% in the second quarter. Signaturefd LLC now owns 3,797 shares of the company’s stock worth $40,000 after acquiring an additional 1,597 shares during the period. 82.84% of the stock is owned by institutional investors.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.